T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival
Authors
Keywords
-
Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume 112, Issue 4, Pages 430-435
Publisher
Wiley
Online
2015-08-12
DOI
10.1002/jso.24012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of TLR4 and B7-H1 on Immune Escape of Urothelial Bladder Cancer and its Clinical Significance
- (2014) Yong-Hua Wang et al. Asian Pacific Journal of Cancer Prevention
- INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract
- (2014) Hsiang-Ying Lee et al. JOURNAL OF SURGICAL ONCOLOGY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Prognostic Value of T Cell Immunoglobulin Mucin-3 in Prostate Cancer
- (2013) Yong-Rui Piao et al. Asian Pacific Journal of Cancer Prevention
- Molecular Pathways: Coexpression of Immune Checkpoint Molecules: Signaling Pathways and Implications for Cancer Immunotherapy
- (2013) C. J. Nirschl et al. CLINICAL CANCER RESEARCH
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
- (2013) Marko Babjuk et al. EUROPEAN UROLOGY
- Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
- (2013) Yang Cao et al. PLoS One
- Tim-3 Expression Defines Regulatory T Cells in Human Tumors
- (2013) Jing Yan et al. PLoS One
- Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
- (2013) Jing Jiang et al. PLoS One
- Ectopic Expression of TIM-3 in Lung Cancers
- (2012) Xuewei Zhuang et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Tim-3, a negative regulator of anti-tumor immunity
- (2012) Ana Carrizosa Anderson CURRENT OPINION IN IMMUNOLOGY
- Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
- (2011) Q. Zhou et al. BLOOD
- Prospects for TIM3-Targeted Antitumor Immunotherapy
- (2011) S. F. Ngiow et al. CANCER RESEARCH
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started